Trial intelligence / Profile preview

MUST Trial: Fluocinolone Implant vs Systemic Therapy

NCT00132691Phase 4Completed

Sponsor
Johns Hopkins Center for Clinical Trials and Evidence Synthesis
Start
Sep 2005
Primary completion
Dec 2010
Modality
Orthosteric Ligands
Countries
3
01

Overview

A Phase 4 trial of fluocinolone in intermediate uveitis (IU), posterior uveitis, panuveitis, sponsored by Johns Hopkins Center for Clinical Trials and Evidence Synthesis. Started Sep 2005; status: completed.

02

Drugs

fluocinolone
03

Conditions

intermediate uveitis (IU)posterior uveitispanuveitis

Beyond the preview

Go deeper on NCT00132691.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00132691.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call